MetaCap

Compass Therapeutics Earnings

NASDAQ: CMPXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

1.02+0.0219 (+2.19%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

Next earnings date

Wed, Nov 4, 2026

Fiscal period

Sep/2026

EPS estimate

$-0.12

Compass Therapeutics earnings summary

Compass Therapeutics is scheduled to report Sep/2026 earnings on Nov 4, 2026, with analysts expecting EPS of $-0.12.

Summary generated from market data by MetaCap's automated system. Methodology

Related